These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11421558)

  • 1. Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: review of the evidence in animals and humans.
    Bell DS; Ovalle F
    Endocr Pract; 2001; 7(2):135-8. PubMed ID: 11421558
    [No Abstract]   [Full Text] [Related]  

  • 2. Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
    Kane JP
    Diabetes Technol Ther; 2002; 4(2):153-5. PubMed ID: 12079618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
    Samraj GP; Kuritzky L; Quillen DM
    Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 6. From fat-free mice, the skinny on diabetes.
    Gura T
    Science; 1998 Oct; 282(5389):604. PubMed ID: 9841407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of glitazones in therapy of type 2 diabetes: pro].
    Pfohl M
    Dtsch Med Wochenschr; 2001 May; 126(20):605. PubMed ID: 11402928
    [No Abstract]   [Full Text] [Related]  

  • 8. Troglitazone: a new antihyperglycemic agent.
    Vidt DG; Speerhas RA; Reddy SS
    Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone. Is it all over?
    Wagenaar LJ; Kuck EM; Hoekstra JB
    Neth J Med; 1999 Jul; 55(1):4-12. PubMed ID: 10431549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of type 2 diabetes. Blood lipids should not be neglected!].
    MMW Fortschr Med; 2000 Nov; 142(44):56. PubMed ID: 11107815
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thiazolidinediones in type 2 diabetes].
    Baum U
    Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
    [No Abstract]   [Full Text] [Related]  

  • 12. New directions in treating insulin resistance.
    Reusch JE
    Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
    [No Abstract]   [Full Text] [Related]  

  • 13. New therapeutic approaches to reversing insulin resistance.
    Sonnenberg GE; Kotchen TA
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone on diabetes-related outcomes in Hispanic patients.
    Jun JK; Gong WC; Mathur R
    Am J Health Syst Pharm; 2003 Mar; 60(5):469-73. PubMed ID: 12635453
    [No Abstract]   [Full Text] [Related]  

  • 15. Troglitazone's effect on lipoprotein(a) levels.
    Ovalle F; Bell DS
    Diabetes Care; 1999 May; 22(5):859-60. PubMed ID: 10332700
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosiglitazone and type 2 diabetes mellitus.
    Bragg T
    Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
    [No Abstract]   [Full Text] [Related]  

  • 17. Unraveling the mechanism of action of thiazolidinediones.
    Kahn CR; Chen L; Cohen SE
    J Clin Invest; 2000 Dec; 106(11):1305-7. PubMed ID: 11104782
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
    Lotz N
    MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase of lipoprotein (a) with troglitazone.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
    Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.